ImmunityBio, Inc. IBRX
At closeNov 11, 2026, 7:48 PM EST
After hours · Nov 11, 7:48 PM ET
- YTD
- +236.87%
- 1 year
- +211.68%
Discussion (3500)
Sign in to join the discussion
Nap time falling asleep watch IBRX trade :)
I was watching IBRX TRADE it's mostly 100-400 shares big trade is 1000
No institutional buying happening is my bet.
Next catalyst is papillary cis approval which is 80% of bladder cancer cases. ImmunityBio goes profitable with just bladder cancer worldwide.
HIV 3 trials happen one at university of Mn
Second at Rockefeller University and the 3rd is in Thailand
Studies take time but wow potential is a huge market.
I have a gut feeling this is the weekend you don't want to be out or light with IBRX
Just have feeling we get big news very soon
I bought 10,000 more Wednesday at 7.01
600,000 total now go IBRX
If ImmunityBio cures AIDS will that make MSM news? If it does cure ADIS it will destroy a 50-60 billion $ a year business of treating it for ever.
Next 2 quarters should show rapid sales growth and the stock price should rise I believe to $12-$15 on that news alone. Add in a FDA approval $15-$20 soon too
If I was about to become a trillionaire I would buy Anktiva and get treated 1-2/year
Fountain of youth just maybe
I think the board was thrilled getting shares why they know they are going to explode in value soon
So sick of short squeeze talk! Not happening I think institutional and Wall Street are manipulating the price to protect the short interest and without wide spread institutional buying and huge retail buying no short squeeze so let your fantasy go....
PLEASE
Answer the question please some one
